PCRX earnings: a negative outcome, -7.2%

On May 3, 2023, Pacira BioSciences, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.2% in the window around the event. It had already run +9.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.